Form 4: Natera Co-Founder Jonathan Sheena Sells Shares Under 10b5-1 Trading Plans

Natera co-founder Jonathan Sheena sold a total of 6,260 shares of common stock on January 2, 2025, through pre-arranged 10b5-1 trading plans.

Summary

• Jonathan Sheena, a co-founder of Natera, Inc., executed multiple sales of Natera common stock on January 2, 2025.
• These sales were conducted under two pre-established Rule 10b5-1 trading plans.
• The first plan was adopted on December 12, 2023, and the second on June 7, 2024.
• A total of 6,260 shares were sold directly by Sheena, and 2,990 shares were sold indirectly through the Caraluna 1 and Caraluna 2 Trusts.
• The direct sales were executed at weighted average prices ranging from $158.7087 to $160.6685 per share.
• The indirect sales through the trusts were executed at weighted average prices ranging from $158.7333 to $160.6972 per share.
• Following these transactions, Sheena directly owns 254,372 shares and indirectly owns 44,782 shares through the Caraluna 1 Trust and 44,782 shares through the Caraluna 2 Trust.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of stock sales under a pre-arranged trading plan, which is neither positive nor negative. It's a neutral event from an investment perspective.

Risks

• The sales by a company co-founder could be perceived negatively by the market, potentially impacting investor confidence.

Industry Context

This filing is a routine disclosure of insider trading activity, which is common for publicly traded companies. The use of 10b5-1 plans is a standard practice to avoid accusations of insider trading.

Comparison to Industry Standards

• The use of 10b5-1 trading plans is a common practice among executives and major shareholders in publicly traded companies, including those in the biotechnology sector like Natera.
• Companies such as Exact Sciences (EXAS) and Illumina (ILMN) also see similar filings from their executives and major shareholders.
• These filings are a standard part of regulatory compliance and do not necessarily indicate a change in the company's prospects or the executive's confidence in the company.

Stakeholder Impact

• The stock sales could have a minor negative impact on shareholder sentiment, but the use of 10b5-1 plans mitigates this concern.

Key Dates

Keywords

Natera, Jonathan Sheena, insider trading, Form 4, 10b5-1 trading plan, stock sale, share transaction, Caraluna Trust